132 related articles for article (PubMed ID: 38250763)
21. Integrative analysis of miRNA-mRNA expression profiles in esophageal fibrosis after ESD.
Zhang Y; Xu C
Exp Ther Med; 2021 Oct; 22(4):1176. PubMed ID: 34504621
[TBL] [Abstract][Full Text] [Related]
22. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Mari L; Hoefnagel SJM; Zito D; van de Meent M; van Endert P; Calpe S; Sancho Serra MDC; Heemskerk MHM; van Laarhoven HWM; Hulshof MCCM; Gisbertz SS; Medema JP; van Berge Henegouwen MI; Meijer SL; Bergman JJGHM; Milano F; Krishnadath KK
Gastroenterology; 2018 Sep; 155(3):784-798. PubMed ID: 29885883
[TBL] [Abstract][Full Text] [Related]
23. Cancer-related long noncoding RNAs show aberrant expression profiles and competing endogenous RNA potential in esophageal adenocarcinoma.
Yu Y; Chen X; Cang S
Oncol Lett; 2019 Nov; 18(5):4798-4808. PubMed ID: 31611990
[TBL] [Abstract][Full Text] [Related]
24. Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.
Lynam-Lennon N; Bibby BA; Mongan AM; Marignol L; Paxton CN; Geiersbach K; Bronner MP; O'Sullivan J; Reynolds J; Maher SG
Mol Med; 2016 May; 22():388-97. PubMed ID: 27254108
[TBL] [Abstract][Full Text] [Related]
25. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
[TBL] [Abstract][Full Text] [Related]
26. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
27. Network analysis of microRNAs, genes and their regulation in diffuse and follicular B-cell lymphomas.
Hershkovitz-Rokah O; Geva P; Salmon-Divon M; Shpilberg O; Liberman-Aronov S
Oncotarget; 2018 Jan; 9(8):7928-7941. PubMed ID: 29487703
[TBL] [Abstract][Full Text] [Related]
28. Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma.
Li X; Wang Y; Min Q; Zhang W; Teng H; Li C; Zhang K; Shi L; Wang B; Zhan Q
Comput Struct Biotechnol J; 2023; 21():3841-3853. PubMed ID: 37564101
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of miRNA and target mRNAs in esophageal cancer.
Meng XR; Lu P; Mei JZ; Liu GJ; Fan QX
Braz J Med Biol Res; 2014 Sep; 47(9):811-7. PubMed ID: 25098614
[TBL] [Abstract][Full Text] [Related]
30. Evidence that dysplasia related microRNAs in Barrett's esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma.
Xu J; Yin Z; Yang L; Wu F; Fan J; Huang Q; Jin Y; Yang G
Aging (Albany NY); 2020 Sep; 12(17):17062-17078. PubMed ID: 32903213
[TBL] [Abstract][Full Text] [Related]
31. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
Lynam-Lennon N; Heavey S; Sommerville G; Bibby BA; Ffrench B; Quinn J; Gasch C; O'Leary JJ; Gallagher MF; Reynolds JV; Maher SG
Oncotarget; 2017 Feb; 8(7):11400-11413. PubMed ID: 28002789
[TBL] [Abstract][Full Text] [Related]
33. microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity.
Tan X; Ren S; Fu MZ; Ren S; Yang C; Wu X; Chen T; Latham PS; Meltzer SJ; Fu SW
Am J Cancer Res; 2021; 11(7):3594-3610. PubMed ID: 34354862
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
[TBL] [Abstract][Full Text] [Related]
35. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
Wang Y; Zhao Y; Herbst A; Kalinski T; Qin J; Wang X; Jiang Z; Benedix F; Franke S; Wartman T; Camaj P; Halangk W; Kolligs FT; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2016 Nov; 264(5):804-814. PubMed ID: 27501171
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.
Arai T; Fuse M; Goto Y; Kaga K; Kurozumi A; Yamada Y; Sugawara S; Okato A; Ichikawa T; Yamanishi T; Seki N
J Hum Genet; 2018 May; 63(5):543-554. PubMed ID: 29531336
[TBL] [Abstract][Full Text] [Related]
37. NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.
Pandey P; Suyal G; Aprajita ; Pasbola K; Sharma R
Funct Integr Genomics; 2023 Mar; 23(2):111. PubMed ID: 36995552
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.
Mallick R; Patnaik SK; Wani S; Bansal A
Dig Dis Sci; 2016 Apr; 61(4):1039-50. PubMed ID: 26572780
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA profiling of diabetic atherosclerosis in a rat model.
Li Y; Xiao L; Li J; Sun P; Shang L; Zhang J; Zhao Q; Ouyang Y; Li L; Gong K
Eur J Med Res; 2018 Nov; 23(1):55. PubMed ID: 30390707
[TBL] [Abstract][Full Text] [Related]
40. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.
Blum AE; Venkitachalam S; Ravillah D; Chelluboyina AK; Kieber-Emmons AM; Ravi L; Kresak A; Chandar AK; Markowitz SD; Canto MI; Wang JS; Shaheen NJ; Guo Y; Shyr Y; Willis JE; Chak A; Varadan V; Guda K
Gastroenterology; 2019 May; 156(6):1761-1774. PubMed ID: 30768984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
